{"id":12251,"date":"2023-04-17T11:15:17","date_gmt":"2023-04-17T15:15:17","guid":{"rendered":"https:\/\/ccna-ccnv.ca\/?post_type=ccna_publication&#038;p=12251"},"modified":"2025-03-06T11:16:00","modified_gmt":"2025-03-06T16:16:00","slug":"brain-iron-content-in-cerebral-amyloid-angiopathy-using-quantitative-susceptibility-mapping","status":"publish","type":"ccna_publication","link":"https:\/\/ccna-ccnv.ca\/fr\/ccna_publication\/brain-iron-content-in-cerebral-amyloid-angiopathy-using-quantitative-susceptibility-mapping\/","title":{"rendered":"Brain iron content in cerebral amyloid angiopathy using quantitative susceptibility mapping"},"content":{"rendered":"<h2>Abstract<\/h2>\n<p><strong class=\"sub-title\">Introduction:\u00a0<\/strong>Cerebral amyloid angiopathy (CAA) is a small vessel disease that causes covert and symptomatic brain hemorrhaging. We hypothesized that persons with CAA would have increased brain iron content detectable by quantitative susceptibility mapping (QSM) on magnetic resonance imaging (MRI), and that higher iron content would be associated with worse cognition.<\/p>\n<p><strong class=\"sub-title\">Methods:\u00a0<\/strong>Participants with CAA (<i>n<\/i>\u00a0= 21), mild Alzheimer&rsquo;s disease with dementia (AD-dementia;\u00a0<i>n<\/i>\u00a0= 14), and normal controls (NC;\u00a0<i>n<\/i>\u00a0= 83) underwent 3T MRI. Post-processing QSM techniques were applied to obtain susceptibility values for regions of the frontal and occipital lobe, thalamus, caudate, putamen, pallidum, and hippocampus. Linear regression was used to examine differences between groups, and associations with global cognition, controlling for multiple comparisons using the false discovery rate method.<\/p>\n<p><strong class=\"sub-title\">Results:\u00a0<\/strong>No differences were found between regions of interest in CAA compared to NC. In AD, the calcarine sulcus had greater iron than NC (\u03b2 = 0.99 [95% CI: 0.44, 1.53],\u00a0<i>q<\/i>\u00a0&lt; 0.01). However, calcarine sulcus iron content was not associated with global cognition, measured by the Montreal Cognitive Assessment (<i>p<\/i>\u00a0&gt; 0.05 for all participants, NC, CAA, and AD).<\/p>\n<p><strong class=\"sub-title\">Discussion:\u00a0<\/strong>After correcting for multiple comparisons, brain iron content, measured via QSM, was not elevated in CAA compared to NC in this exploratory study.<\/p>\n","protected":false},"author":14,"featured_media":0,"template":"","meta":{"_acf_changed":false},"studies-relation":[153],"class_list":["post-12251","ccna_publication","type-ccna_publication","status-publish","hentry","studies-relation-neuroimaging-fr"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v25.8 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Brain iron content in cerebral amyloid angiopathy using quantitative susceptibility mapping - CCNA - CCNV<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ccna-ccnv.ca\/fr\/ccna_publication\/brain-iron-content-in-cerebral-amyloid-angiopathy-using-quantitative-susceptibility-mapping\/\" \/>\n<meta property=\"og:locale\" content=\"fr_CA\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Brain iron content in cerebral amyloid angiopathy using quantitative susceptibility mapping - CCNA - CCNV\" \/>\n<meta property=\"og:description\" content=\"Abstract Introduction:\u00a0Cerebral amyloid angiopathy (CAA) is a small vessel disease ...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ccna-ccnv.ca\/fr\/ccna_publication\/brain-iron-content-in-cerebral-amyloid-angiopathy-using-quantitative-susceptibility-mapping\/\" \/>\n<meta property=\"og:site_name\" content=\"CCNA - CCNV\" \/>\n<meta property=\"article:modified_time\" content=\"2025-03-06T16:16:00+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ccna-ccnv.ca\/wp-content\/uploads\/2025\/01\/CCNA.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"675\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/ccna-ccnv.ca\/fr\/ccna_publication\/brain-iron-content-in-cerebral-amyloid-angiopathy-using-quantitative-susceptibility-mapping\/\",\"url\":\"https:\/\/ccna-ccnv.ca\/fr\/ccna_publication\/brain-iron-content-in-cerebral-amyloid-angiopathy-using-quantitative-susceptibility-mapping\/\",\"name\":\"Brain iron content in cerebral amyloid angiopathy using quantitative susceptibility mapping - CCNA - CCNV\",\"isPartOf\":{\"@id\":\"https:\/\/ccna-ccnv.ca\/fr\/#website\"},\"datePublished\":\"2023-04-17T15:15:17+00:00\",\"dateModified\":\"2025-03-06T16:16:00+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/ccna-ccnv.ca\/fr\/ccna_publication\/brain-iron-content-in-cerebral-amyloid-angiopathy-using-quantitative-susceptibility-mapping\/#breadcrumb\"},\"inLanguage\":\"fr-CA\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/ccna-ccnv.ca\/fr\/ccna_publication\/brain-iron-content-in-cerebral-amyloid-angiopathy-using-quantitative-susceptibility-mapping\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/ccna-ccnv.ca\/fr\/ccna_publication\/brain-iron-content-in-cerebral-amyloid-angiopathy-using-quantitative-susceptibility-mapping\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/ccna-ccnv.ca\/fr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Brain iron content in cerebral amyloid angiopathy using quantitative susceptibility mapping\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/ccna-ccnv.ca\/fr\/#website\",\"url\":\"https:\/\/ccna-ccnv.ca\/fr\/\",\"name\":\"Canadian Consortium on Neurodegeneration in Aging\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/ccna-ccnv.ca\/fr\/#organization\"},\"alternateName\":\"CCNA - CCNV\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/ccna-ccnv.ca\/fr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-CA\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/ccna-ccnv.ca\/fr\/#organization\",\"name\":\"Canadian Consortium on Neurodegeneration in Aging\",\"alternateName\":\"CCNA - CCNV\",\"url\":\"https:\/\/ccna-ccnv.ca\/fr\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-CA\",\"@id\":\"https:\/\/ccna-ccnv.ca\/fr\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/ccna-ccnv.ca\/wp-content\/uploads\/2025\/01\/ccna-logo-on-white-background.jpg\",\"contentUrl\":\"https:\/\/ccna-ccnv.ca\/wp-content\/uploads\/2025\/01\/ccna-logo-on-white-background.jpg\",\"width\":696,\"height\":696,\"caption\":\"Canadian Consortium on Neurodegeneration in Aging\"},\"image\":{\"@id\":\"https:\/\/ccna-ccnv.ca\/fr\/#\/schema\/logo\/image\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Brain iron content in cerebral amyloid angiopathy using quantitative susceptibility mapping - CCNA - CCNV","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ccna-ccnv.ca\/fr\/ccna_publication\/brain-iron-content-in-cerebral-amyloid-angiopathy-using-quantitative-susceptibility-mapping\/","og_locale":"fr_CA","og_type":"article","og_title":"Brain iron content in cerebral amyloid angiopathy using quantitative susceptibility mapping - CCNA - CCNV","og_description":"Abstract Introduction:\u00a0Cerebral amyloid angiopathy (CAA) is a small vessel disease ...","og_url":"https:\/\/ccna-ccnv.ca\/fr\/ccna_publication\/brain-iron-content-in-cerebral-amyloid-angiopathy-using-quantitative-susceptibility-mapping\/","og_site_name":"CCNA - CCNV","article_modified_time":"2025-03-06T16:16:00+00:00","og_image":[{"width":1200,"height":675,"url":"https:\/\/ccna-ccnv.ca\/wp-content\/uploads\/2025\/01\/CCNA.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/ccna-ccnv.ca\/fr\/ccna_publication\/brain-iron-content-in-cerebral-amyloid-angiopathy-using-quantitative-susceptibility-mapping\/","url":"https:\/\/ccna-ccnv.ca\/fr\/ccna_publication\/brain-iron-content-in-cerebral-amyloid-angiopathy-using-quantitative-susceptibility-mapping\/","name":"Brain iron content in cerebral amyloid angiopathy using quantitative susceptibility mapping - CCNA - CCNV","isPartOf":{"@id":"https:\/\/ccna-ccnv.ca\/fr\/#website"},"datePublished":"2023-04-17T15:15:17+00:00","dateModified":"2025-03-06T16:16:00+00:00","breadcrumb":{"@id":"https:\/\/ccna-ccnv.ca\/fr\/ccna_publication\/brain-iron-content-in-cerebral-amyloid-angiopathy-using-quantitative-susceptibility-mapping\/#breadcrumb"},"inLanguage":"fr-CA","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ccna-ccnv.ca\/fr\/ccna_publication\/brain-iron-content-in-cerebral-amyloid-angiopathy-using-quantitative-susceptibility-mapping\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/ccna-ccnv.ca\/fr\/ccna_publication\/brain-iron-content-in-cerebral-amyloid-angiopathy-using-quantitative-susceptibility-mapping\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ccna-ccnv.ca\/fr\/"},{"@type":"ListItem","position":2,"name":"Brain iron content in cerebral amyloid angiopathy using quantitative susceptibility mapping"}]},{"@type":"WebSite","@id":"https:\/\/ccna-ccnv.ca\/fr\/#website","url":"https:\/\/ccna-ccnv.ca\/fr\/","name":"Canadian Consortium on Neurodegeneration in Aging","description":"","publisher":{"@id":"https:\/\/ccna-ccnv.ca\/fr\/#organization"},"alternateName":"CCNA - CCNV","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ccna-ccnv.ca\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-CA"},{"@type":"Organization","@id":"https:\/\/ccna-ccnv.ca\/fr\/#organization","name":"Canadian Consortium on Neurodegeneration in Aging","alternateName":"CCNA - CCNV","url":"https:\/\/ccna-ccnv.ca\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-CA","@id":"https:\/\/ccna-ccnv.ca\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/ccna-ccnv.ca\/wp-content\/uploads\/2025\/01\/ccna-logo-on-white-background.jpg","contentUrl":"https:\/\/ccna-ccnv.ca\/wp-content\/uploads\/2025\/01\/ccna-logo-on-white-background.jpg","width":696,"height":696,"caption":"Canadian Consortium on Neurodegeneration in Aging"},"image":{"@id":"https:\/\/ccna-ccnv.ca\/fr\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/ccna-ccnv.ca\/fr\/wp-json\/wp\/v2\/ccna_publication\/12251","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ccna-ccnv.ca\/fr\/wp-json\/wp\/v2\/ccna_publication"}],"about":[{"href":"https:\/\/ccna-ccnv.ca\/fr\/wp-json\/wp\/v2\/types\/ccna_publication"}],"author":[{"embeddable":true,"href":"https:\/\/ccna-ccnv.ca\/fr\/wp-json\/wp\/v2\/users\/14"}],"wp:attachment":[{"href":"https:\/\/ccna-ccnv.ca\/fr\/wp-json\/wp\/v2\/media?parent=12251"}],"wp:term":[{"taxonomy":"studies-relation","embeddable":true,"href":"https:\/\/ccna-ccnv.ca\/fr\/wp-json\/wp\/v2\/studies-relation?post=12251"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}